Characterization of a new neuropeptide Y Y5 agonist radioligand: [ 125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP

Neuropeptides

Volumn 38, Issue 4, 2004, Pages 163-174

  Dumont, Yvan ^a   Thakur, Mira ^a   Beck Sickinger, Annette ^b   Fournier, Alain ^c   Quirion, Rémi ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

BIBO3304, (R) N 4 (aminocarbonylaminomethyl) phenyl methyl N2 (diphenylacetyl) argininamide trifluoroacetate; BIBP3226, R N2 (diphenylacetyl) N (4 hydroxyphenyl) methylargininamide

Indexed keywords

1 NAPHTHALENESULFONIC ACID [4 [(4 AMINO 2 QUINAZOLINYLAMINO)METHYL]CYCLOHEXYLMETHYL]AMIDE; 2 AMINO 2 METHYLPROPIONIC ACID; [[(NAPHTHALEN 2 YLMETHYL)AMINO]METHYL] 2 NITROBENZENE SULFONAMIDE; BENZENE DERIVATIVE; COMPLEMENTARY DNA; GLUTAMINE; GR 231118; GR 23118; IODINE 125; JCF 109; N [2 [1,2 DIHYDRO 3,5(4H) DIOXO 1,2 DIPHENYL 1,2,4 TRIAZOL 4 YL]ETHYL] N2 [[1 [2 [4 [5,11 DIHYDRO 6(6H) OXODIBENZ[B,E]AZEPIN 11 YL] 1 PIPERAZINYL] 2 OXOETHYL]CYCLOPENTYL]ACETYL]ARGININAMIDE; N1 [[[[(4 AMINO 2 QUINAZOLINYL)AMINO]METHYL]CYCLOHEXYL]METHYL] 1 NAPHTHALENESULFONAMIDE; N2 DIPHENYLACETYL N (4 UREIDOMETHYLBENZYL)ARGININAMIDE; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y [19-23]; NEUROPEPTIDE Y DERIVATIVE; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y5 RECEPTOR AGONIST; PANCREAS POLYPEPTIDE; PANCREAS POLYPEPTIDE[1-7]; PEPTIDE DERIVATIVE; RADIOLIGAND; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AUTORADIOGRAPHY; BINDING AFFINITY; BINDING COMPETITION; BINDING SITE; BRAIN HOMOGENATE; BRAIN MEMBRANE; BRAIN REGION; CONTROLLED STUDY; EMBRYO; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REVIEW;

ANIMALS; BRAIN; CELL LINE; HUMANS; IODINE RADIOISOTOPES; LIGANDS; MALE; NEUROPEPTIDE Y; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROPEPTIDE Y;

EID: 4344594124     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2004.04.007     Document Type: Review

References (54)

1. Berglund M.M., Schober D.A., Esterman M.A., Gehlert D.R. Neuropeptide Y Y4 receptor homodimers dissociate upon agonist stimulation. J. Pharmacol. Exp. Ther. 307:2003;1120-1126
2. Cabrele C., Beck-Sickinger A.G. Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family. J. Peptide Sci. 6:2000;97-122
3. Cabrele C., Langer M., Bader R., Wieland H.A., Doods H.N., Zerbe O., Beck-Sickinger A.G. The first selective agonist for the neuropeptide Y Y5 receptor increases food intake in rats. J. Biol. Chem. 275:2000;36043-36048
4. Cabrele C., Wieland H.A., Langer M., Stidsen C.E., Beck-Sickinger A.G. Y-receptor affinity modulation by the design of pancreatic polypeptide/ neuropeptide Y chimera led to Y5-receptor ligands with picomolar affinity. Peptides. 22:2001;365-378
5. Campbell R.E., Ffrench-Mullen J.M., Cowley M.A., Smith M.S., Grove K.L. Hypothalamic circuitry of neuropeptide Y regulation of neuroendocrine function and food intake via the Y5 receptor subtype. Neuroendocrinology. 74:2001;106-119
6. Criscione L., Rigollier P., Batzl-Hartmann C., Rueger H., Stricker-Krongrad A., Wyss P., Brunner L., Whitebread S., Yamaguchi Y., Gerald C., Heurich R.O., Walker M.W., Chiesi M., Schilling W., Hofbauer K.G., Levens N. Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor. J. Clin. Invest. 102:1998;2136-2145
7. Dinger M.C., Bader J.E., Kobor A.D., Kretzschmar A.K., Beck-Sickinger A.G. Homodimerization of neuropeptide Y receptors investigated by fluorescence resonance energy transfer in living cells. J. Biol. Chem. 278:2003;10562-10571
8. Doods H.N., Wienen W., Entzeroth M., Rudolf K., Eberlein W., Engel W., Wieland H.A. Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226. J. Pharmacol. Exp. Ther. 275:1995;136-142
9. Doods H.N., Wieland H.A., Engel W., Eberlein W., Willim K.D., Entzeroth M., Wienen W., Rudolf K. BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: a review of its pharmacological properties. Regul. Pept. 65:1996;71-77
10. Doods H., Gaida W., Wieland H.A., Dollinger H., Schnorrenberg G., Esser F., Engel W., Eberlein W., Rudolf K. BIIE0246: a selective and high affinity neuropeptide Y Y2 receptor antagonist. Eur. J. Pharmacol. 384:1999;R3-R5
11. Dumont Y., Fournier A., St Pierre S., Quirion R. Characterization of neuropeptide Y binding sites in rat brain membrane preparations using [125I][Leu31,Pro34]peptide YY and [125I]peptide YY3-36 as selective Y1 and Y2 radioligands. J. Pharmacol. Exp. Ther. 272:1995;673-680
12. Dumont Y., Fournier A., St Pierre S., Quirion R. Autoradiographic distribution of[125I][Leu31,Pro34]PYY and [125I]PYY3-36 binding sites in the rat brain evaluated with two newly developed Y1 and Y2 receptor radioligands. Synapse. 22:1996;139-158
13. Dumont Y., St Pierre J.A., Quirion R. Comparative autoradiographic distribution of neuropeptide Y Y1 receptors visualized with the Y1 receptor agonist [125I][Leu31,Pro34]PYY and the non-peptide antagonist [3H]BIBP3226. Neuroreport. 7:1996;901-904
14. Dumont Y., Jacques D., St Pierre J.A., Quirion R. Neuropeptide Y receptor types in the mammalian brain: species differences and status in the human central nervous system. Grundemar L., Bloom S.R. Neuropeptide Y and Drug Development. 1997;57-86 Academic Press, London
15. Dumont Y., Fournier A., Quirion R. Expression and characterization of the neuropeptide Y Y5 receptor subtype in the rat brain. J. Neurosci. 18:1998;5565-5574
16. Dumont Y., Cadieux A., Doods H., Fournier A., Quirion R. Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems: BIB03304 (Y1) and CGP71683A (Y5). Can. J. Physiol. Pharmacol. 78:2000;116-125
17. Dumont Y., Cadieux A., Doods H., Pheng L.H., Abounader R., Hamel E., Jacques D., Regoli D., Quirion R. BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y2 receptor antagonist. Br. J. Pharmacol. 129:2000;1075-1088
18. Dumont Y., Jacques D., St Pierre J.A., Tong Y., Parker R., Herzog H., Quirion R. Neuropeptide Y, peptide YY and pancreatic polypeptide receptor proteins and mRNAs in mammalian brains. Quirion R., Bjorklund A., Hokfelt T. Handbook of Chemical Neuroanatomy, Peptide Receptor. vol. 16:2000;375-475 Elservier, Amsterdam
19. Dumont Y., Redrobe J.P., Quirion R. Neuropeptide Y receptors. Pangalos N.N., Davies C.H. Understanding G Protein-coupled Receptors and their Role in the CNS (Molecular and Cellular Neurobiology). 2002;372-401 Oxford University Press, Oxford
20. Dumont, Y., Thakur, M., Fournier, A., Beck-Sickinger, A., Quirion, R., 2002. Further characterization of neuropeptide Y Y5 receptor binding profile in the rat brain. Program No. 637.1. 2002 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2002
21. Dumont Y., Thakur M., Beck-Sickinger A., Fournier A., Quirion R. Development and characterization of a highly selective neuropeptide Y Y5 receptor agonist radioligand: [(125)I][hPP(1-17), Ala(31), Aib(32)]NPY. Br. J. Pharmacol. 139:2003;1360-1368
22. Dumont Y., Chabot J.G., Quirion R. Receptor autoradiography as mean to explore the possible functional relevance of neuropeptides: focus on new agonists and antagonists to study natriuretic peptides, neuropeptide Y and calcitonin gene-related peptides. Peptides. 25:2004;365-391
23. Dumont, Y., Fournier, A., Quirion, R., 2004b. On the putative existence of additional neuropeptide Y receptor subtypes in the rat brain. Abstract presented at the 7th International NPY meeting, Coimbra, Portugal, S1.1
24. Entzeroth M., Braunger H., Eberlein W., Engel W., Rudolf K., Wienen W., Wieland H.A., Willim K.D., Doods H.N. Labeling of neuropeptide Y receptors in SK-N-MC cells using the novel, nonpeptide Y1 receptor-selective antagonist [3H]BIBP3226. Eur. J. Pharmacol. 278:1995;239-242
25. Eva C., Oberto A., Sprengel R., Genazzani E. The murine NPY-1 receptor gene. Structure and delineation of tissue-specific expression. FEBS Lett. 314:1992;285-288
26. Feletou M., Nicolas J.P., Rodriguez M., Beauverger P., Galizzi J.P., Boutin J.A., Duhault J. NPY receptor subtype in the rabbit isolated ileum. Br. J. Pharmacol. 127:1999;795-801
27. Forest M., Martel J.C., St Pierre S., Quirion R., Fournier A. Structural study of the N-terminal segment of neuropeptide tyrosine. J. Med. Chem. 33:1990;1615-1619
28. Gehlert D.R., Gackenheimer S.L., Schober D.A., Beavers L., Gadski R., Burnett J.P., Mayne N., Lundell I., Larhammar D. The neuropeptide Y Y1 receptor selective radioligand, [125I][Leu31,Pro34]peptide YY, is also a high affinity radioligand for human pancreatic polypeptide 1 receptors. Eur. J. Pharmacol. 318:1996;485-490
29. Gehlert D.R., Schober D.A., Gackenheimer S.L., Beavers L., Gadski R., Lundell I., Larhammar D. [125I]Leu31,Pro34-PYY is a high affinity radioligand for rat PP1/Y4 and Y1 receptors: evidence for heterogeneity in pancreatic polypeptide receptors. Peptides. 18:1997;397-401
30. Gehlert D.R. Role of hypothalamic neuropeptide Y in feeding and obesity. Neuropeptides. 33:1999;329-338
31. Gerald C., Walker M.W., Vaysse P.J., He C., Branchek T.A., Weinshank R.L. Expression cloning and pharmacological characterization of a human hippocampal neuropeptide Y/peptide YY Y2 receptor subtype. J. Biol. Chem. 270:1995;26758-26761
32. Gerald C., Walker M.W., Criscione L., Gustafson E.L., Batzl-Hartmann C., Smith K.E., Vaysse P., Durkin M.M., Laz T.M., Linemeyer D.L., Schaffhauser A.O., Whitebread S., Hofbauer K.G., Taber R.I., Branchek T.A., Weinshank R.L. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature. 382:1996;168-171
33. Grove K.L., Campbell R.E., Ffrench-Mullen J.M., Cowley M.A., Smith M.S. Neuropeptide Y Y5 receptor protein in the cortical/limbic system and brainstem of the rat: expression on gamma-aminobutyric acid and corticotropin-releasing hormone neurons. Neuroscience. 100:2000;731-740
34. Hunter W.M., Greenwood F.C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 194:1962;495-496
35. Jacques D., Cadieux A., Dumont Y., Quirion R. Apparent affinity and potency of BIBP3226, a non-peptide neuropeptide Y receptor antagonist, on purported neuropeptide Y Y1, Y2 and Y3 receptors. Eur. J. Pharmacol. 278:1995;R3-R5
36. Juaneda C., Dumont Y., Chabot J.G., Fournier A., Quirion R. Adrenomedullin receptor binding sites in rat brain and peripheral tissue. Eur. J. Pharmacol. 474:2003;165-174
37. Kalra S.P., Crowley W.R. Neuropeptide Y: a novel neuroendocrine peptide in the control of pituitary hormone secretion, and its relation to luteinizing hormone. Front. Neuroendocrinol. 13:1992;1-46
38. Kask A., Harro J., von Horsten S., Redrobe J.P., Dumont Y., Quirion R. The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci. Biobehav. Rev. 26:2002;259-283
39. Krause J., Eva C., Seeburg P.H., Sprengel R. Neuropeptide Y1 subtype pharmacology of a recombinantly expressed neuropeptide receptor. Mol. Pharmacol. 41:1992;817-821
40. Lundell I., Blomqvist A.G., Berglund M.M., Schober D.A., Johnson D., Statnick M.A., Gadski R.A., Gehlert D.R., Larhammar D. Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY. J. Biol. Chem. 270:1995;29123-29128
41. Martel J.C., Fournier A., St Pierre S., Quirion R. Quantitative autoradiographic distribution of [125I]Bolton-Hunter neuropeptide Y receptor binding sites in rat brain. Comparison with [125I]peptide YY receptor sites. Neuroscience. 36:1990;255-283
42. Michel M.C., Beck-Sickinger A., Cox H., Doods H.N., Herzog H., Larhammar D., Quirion R., Schwartz T., Westfall T. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev. 50:1998;143-150
43. Parker E.M., Babij C.K., Balasubramaniam A., Burrier R.E., Guzzi M., Hamud F., Mukhopadhyay G., Rudinski M.S., Tao Z., Tice M., Xia L., Mullins D.E., Salisbury B.G. GR231118 (1229U91) and other analogues of the C-terminusof neuropeptide Y are potent neuropeptide Y Y1 receptor antagonists and neuropeptide Y Y4 receptor agonists. Eur. J. Pharmacol. 349:1998;97-105
44. Redrobe J.P., Dumont Y., St Pierre J.A., Quirion R. Multiple receptors for neuropeptide Y in the hippocampus: putative roles in seizures and cognition. Brain Res. 848:1999;153-166
45. Redrobe J.P., Dumont Y., Quirion R. Neuropeptide Y (NPY) and depression: from animal studies to the human condition. Life Sci. 71:2002;2921-2937
46. Schober, D.A., Berglund, M.M., Gehlert, D.R., 2003. Neuropeptide Y (NPY Y1 and Y5) receptors form constitutive dimers that elicit and enhanced response to a Y5 agonists. Program No. 615.4. 2003 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience
47. Schober, D.A., Berglund, M.M., Gehlert, D.R., 2004. Co-expression of neuropeptide Y Y1 and Y5 receptors forms a constitutive heterodimer with distinct functional properties. Abstract presented at the 7th International NPY meeting, Coimbra, Portugal, P1.6
48. Tatemoto K., Carlquist M., Mutt V. Neuropeptide Y - a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature. 296:1982;659-660
49. Tong Y., Dumont Y., Shen S.H., Herzog H., Shine J., Quirion R. Expression of the neuropeptide Y Y1 receptor in human embryonic kidney 293 cells: ligand binding characteristics, in situ hybridization and receptor autoradiography. Mol. Brain Res. 34:1995;303-308
50. Trinh T., Dumont Y., Quirion R. High levels of specific neuropeptide Y/pancreatic polypeptide receptors in the rat hypothalamus and brainstem. Eur. J. Pharmacol. 318:1996;R1-R3
51. Vezzani A., Sperk G., Colmers W.F. Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci. 22:1999;25-30
52. Wieland H.A., Engel W., Eberlein W., Rudolf K., Doods H.N. Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents. Br. J. Pharmacol. 125:1998;549-555
53. Wolak M.L., DeJoseph M.R., Cator A.D., Mokashi A.S., Brownfield M.S., Urban J.H. Comparative distribution of neuropeptide Y Y1 and Y5 receptors in the rat brain by using immunohistochemistry. J. Comp. Neurol. 464:2003;285-311
54. Yamamura H.I., Enna S.J., Kuhar M.J. Neurotransmitter Receptor Binding. 1978;Raven Press, NewYork